Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-01-17 00:00:00 ET · period of report 2023-01-13 · accession 0001567619-23-000965 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-17 | 2023-01-13 | BMRN | Mueller Brian | EVP, CFO | S - Sale+OE | $114.50 | -2,500 | 27.7K | -8% | -$286.2K |
| D | 2023-01-17 | 2023-01-13 | BMRN | Mueller Brian | EVP, CFO | M - OptEx | $63.10 | +2,500 | 30.2K | +9% | +$157.8K |
| D | 2023-01-17 | 2023-01-13 | BMRN | Mueller Brian | EVP, CFO | M - OptEx | $0.00 | -2,500 | 5,000 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-13 | S | D | 2,500 | $114.50 | 27,746 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on March 14, 2022. |
| 2 | Common | Common Stock | 2023-01-13 | M | A | 2,500 | $63.10 | 30,246 | D | — | — | (F1) Trade made pursuant to a 10b5-1 plan executed on March 14, 2022. |
| 3 | Derivative | Stock Option (Right to buy Common Stock) | 2023-01-13 | M | D | 2,500 | $0.00 | 5,000 | D | $63.10 · 2014-12-04 to 2024-06-03 | 2,500 Common Stock | (F1) Trade made pursuant to a 10b5-1 plan executed on March 14, 2022. (F2) Reflects the number of options outstanding after the transactions from this specific stock option grant. |